Reply 2: NICE guidelines on drugs for colorectal cancer

por Ross, P J, Cunningham, D
Publicado 2003

Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma

por Assersohn, L, Norman, A, Cunningham, D, Benepal, T, Ross, P J, Oates, J
Publicado 1999

Phase I study of irinotecan and raltitrexed in patients with advanced astrointestinal tract adenocarcinoma

por Ford, H E R, Cunningham, D, Ross, P J, Rao, S, Aherne, G W, Benepal, T S, Price, T, Massey, A, Vernillet, L
Publicado 2000

Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

por Ross, P J, Ashley, S, Norton, A, Priest, K, Waters, J S, Eisen, T, Smith, I E, O'Brien, M E R
Publicado 2004

Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer

por Rao, S, Cunningham, D, Price, T, Hill, M E, Ross, P J, Tebbutt, N, Norman, A R, Oates, J, Shellito, P
Publicado 2004

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom

por Palmer, D H, Hussain, S A, Smith, A J, Hargreaves, S, Ma, Y T, Hull, D, Johnson, P J, Ross, P J
Publicado 2013

Systematic alteration of ATAC-seq for profiling open chromatin in cryopreserved nuclei preparations from livestock tissues

por Halstead, M. M., Kern, C., Saelao, P., Chanthavixay, G., Wang, Y., Delany, M. E., Zhou, H., Ross, P. J.
Publicado 2020

The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people

por Kalsi, T, Babic-Illman, G, Ross, P J, Maisey, N R, Hughes, S, Fields, P, Martin, F C, Wang, Y, Harari, D
Publicado 2015

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

por Rao, S, Cunningham, D, Hawkins, R E, Hill, M E, Smith, D, Daniel, F, Ross, P J, Oates, J, Norman, A R
Publicado 2005

Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer

por Saini, A, Norman, A R, Cunningham, D, Chau, I, Hill, M, Tait, D, Hickish, T, Iveson, T, Lofts, F, Jodrell, D, Ross, P J, Oates, J
Publicado 2003

Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with i...

por Chau, I, Norman, A R, Cunningham, D, Waters, J S, Topham, C, Middleton, G, Hill, M, Ross, P J, Katopodis, R, Stewart, G, Oates, J R
Publicado 2004

Identification of long non-coding RNA in the horse transcriptome

por Scott, E. Y., Mansour, T., Bellone, R. R., Brown, C. T., Mienaltowski, M. J., Penedo, M. C., Ross, P. J., Valberg, S. J., Murray, J. D., Finno, C. J.
Publicado 2017

Tissue resolved, gene structure refined equine transcriptome

por Mansour, T. A., Scott, E. Y., Finno, C. J., Bellone, R. R., Mienaltowski, M. J., Penedo, M. C., Ross, P. J., Valberg, S. J., Murray, J. D., Brown, C. T.
Publicado 2017

Results of a single-arm pilot study of (32)P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy

por Ross, P.J., Wasan, H.S., Croagh, D., Nikfarjam, M., Nguyen, N., Aghmesheh, M., Nagrial, A.M., Bartholomeusz, D., Hendlisz, A., Ajithkumar, T., Iwuji, C., Wilson, N.E., Turner, D.M., James, D.C., Young, E., Harris, M.T.
Publicado 2021

Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials

por Chau, I, Cunningham, D, Russell, C, Norman, A R, Kurzawinski, T, Harper, P, Harrison, P, Middleton, G, Daniels, F, Hickish, T, Prendeville, J, Ross, P J, Theis, B, Hull, R, Walker, M, Shankley, N, Kalindjian, B, Murray, G, Gillbanks, A, Black, J
Publicado 2006